Suchergebnisse - "Brown, Jennifer R"

PubPharm (35)

1

Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL

enthalten in: Blood | 2024

von Woyach, J. | Perez Burbano, G. | Ruppert, A. | +29

2

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

enthalten in: Blood advances | 2024

von Ahn, I. | Brander, D. | Ren, Y. | +20

3

A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma

enthalten in: Annals of hematology | 2024

von Merryman, R. | Redd, R. | Freedman, A. | +22

4

Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA) : a randomised, controlled, phase 3 trial

enthalten in: The Lancet. Oncology | 2022

von Tam, C. | Brown, J. | Kahl, B. | +28

CommentIn: Lancet Oncol. 2022 Aug;23(8):965-967. - PMID 35810752

5

A T cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemia

enthalten in: Leukemia | 2022

von Gadi, D. | Griffith, A. | Tyekucheva, S. | +16

6

Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens : Alliance A041202

enthalten in: Leukemia | 2021

von Ruppert, A. | Booth, A. | Ding, W. | +17

7

The future of antibody therapy in chronic lymphocytic leukemia

enthalten in: Expert opinion on emerging drugs | 2021

von Crombie, J. | Brown, J.

8

A phase 1b/2 study of duvelisib in combination with FCR (DFCR) for frontline therapy for younger CLL patients

enthalten in: Leukemia | 2021

von Davids, M. | Fisher, D. | Tyekucheva, S. | +9

9

Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma

enthalten in: Blood advances | 2020

von Merryman, R. | Edwin, N. | Redd, R. | +21

10

For CLL cells, there's no place like home

enthalten in: Leukemia & lymphoma | 2019

von Lampson, B. | Brown, J.

CommentOn: Leuk Lymphoma. 2019 Dec;60(14):3461-3469. - PMID 31352850